Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cerexa Inc.
The firms hope academic research can yield first-in-class therapies and spinout companies. Also, Yale unveils research alliances with three biotechs.
In tandem with buying the rest of Kleo, Tonix licenses molecular degradation technology from Yale. Neurogene, University of Dundee partner on cell therapies for neurological disorders.
NIH’s National Cancer Institute licensed two experimental cancer therapies in the past month to biopharma firms, leading a heavy slate of cancer-focused tech transfer deal-making.
Heads of vaccines development at partners GSK and Sanofi:“This is not a sprint, it’s a marathon.”